These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs. Dreyfuss J, Shaw JM, Ross JJ. J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144 [Abstract] [Full Text] [Related]
8. Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations. Knudsen P. Acta Psychiatr Scand Suppl; 1985 Sep; 322():51-75. PubMed ID: 2866666 [Abstract] [Full Text] [Related]
9. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. Altamura AC, Sassella F, Santini A, Montresor C, Fumagalli S, Mundo E. Drugs; 2003 Sep; 63(5):493-512. PubMed ID: 12600227 [Abstract] [Full Text] [Related]
10. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels. Jrgensen A, Overø KF. Acta Psychiatr Scand Suppl; 1980 Sep; 279():41-54. PubMed ID: 6931472 [Abstract] [Full Text] [Related]
11. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate. Viala A, Ba B, Durand A, Gouezo F, Hou N, Jørgensen A. Psychopharmacology (Berl); 1988 Sep; 94(3):293-7. PubMed ID: 2895936 [Abstract] [Full Text] [Related]
12. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities. Citrome L, Jaffe A, Levine J. Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia. Wiles DH, McCreadie RG, Whitehead A. Psychopharmacology (Berl); 1990 Jun; 101(2):274-81. PubMed ID: 2349370 [Abstract] [Full Text] [Related]